33 results about "Stomach motility" patented technology

The invention relates to new functions and applications of trametes lactinea(Berk.)Pat. or extractives and trametenloic acid B. The substance trametes lactinea(Berk.)Pat has the functions of digestive gastric ulcer resistance, and nonulcerative-indigestion resistance through increasing of gastric motility. The trametes lactinea(Berk.)Pat. or the extractives and the trametenloic acid B have certain inbibitional effects on cell proliferation of gastric cancer cells, esophagus cancer cells Eca-109 and colorectal cancer cells LOVO, and has a wide range of research value and mass production and edible value in dugs for digestive system and gastric cancer resisting and the like.

The invention provides various devices for delivering Glucagon-Like Peptide-1 (7-36), in various infusion patterns and rates, to optimally stimulate carbohydrate metabolism, to inhibit gastropancreatic secretion and gastric motility, and to treat various disease conditions (including diabete) as described in the instant specification. The devices and methods of the invention provide various ways to deliver doses (escalating, constant, on demand, etc.) of GLP-1 in response to different patient need.

Disclosed herein is a method of treatment of gastric motility disorders and of improving gastric motility comprising treatment with the NK-1 receptor antagonist, tradipitant.

The invention relates to a simethicone compound recipe liquid composition and a preparation method and application thereof. The simethicone compound recipe liquid composition comprises simethicone andgastric motility promoting medicines or pharmaceutically-acceptable salts of the gastric motility promoting medicines, wherein the gastric motility promoting medicines are one or two of Itopride, mosapride and cisapride, and the mass ratio of the simethicone to the gastric motility promoting medicines or the pharmaceutically-acceptable salts of the gastric motility promoting medicines is (10-40)to 1. The simethicone and the gastric motility promoting medicines are compounded in a specific proportion and are made into the form of a liquid preparation, so that the defoaming capacity is strengthened, and defoaming can be completed only within 3-5 seconds; and besides, the stability is good, and the simethicone compound recipe liquid composition can still maintain better preparation shape and better defoaming capacity after being stored for 30 days.

The invention discloses chicken silage capable of improving meat quality and a preparation technology thereof. The chicken silage capable of improving meat quality comprises the following raw materials in parts by weight: 55-65 parts of Russian comfrey, 50-60 parts of ryegrass, 40-50 parts of lotus japonicus, 30-40 parts of oat germ powder, 16-20 parts of glucomannan-coated calcite, 2-3 parts of asilage fermentation agent, and 0.8-1.2 parts of feed additives; and the feed additives comprise moringa seed oil, nuciferine, L-carnitine tartrate, mint powder, allicin, saccharicter-penin, beta-carotene, plant active selenium, selenate polysaccharides and chloride choline. The preparation technology of the chicken silage capable of improving meat quality comprises the following steps: S1, preparing a semi-dry premix; S2, tightly pressing the semi-dry premix until the volume of the semi-dry premix is reduced by 55-65%, and carrying out wrapped fermentation, wherein extrusion is performed during the fermentation process once every 3 days; S3, preparing glucomannan-coated calcite; and S4, carrying out uniform blending and granulation. The chicken silage produced by the preparation technology is capable of effectively preventing excessive fatty acid accumulation in chicken meat, as well as endowing the chicken meat with natural grass aroma, so as to improve quality and flavor of the chicken meat; moreover, the chicken silage is also capable of promoting gastrointestinal peristalsis of chicken, as well as improving gastric motility.

The invention discloses a Chinese herbal granule for treating diabetes gastroparesis, and relates to a Chinese herbal preparation. The Chinese herbal granule for treating the diabetes gastroparesis is characterized by being prepared by, by mass, the following traditional Chinese medicine raw materials of 7.2-8.8% of radix trichosanthis, 6-7.4% of rhizoma phragmitis, 5.4-6.6% of moutan bark, 3.6-4.4% of wahlenbergia marginata, 5.4-6.6% of malt sugar, 6-7.4% of paederia scandens, 7.2-8.8% of rice sprouts, 5.4-6.6% of agilawood, 5.9-7.3% of rhizoma cyperi, 7.2-8.8% of pericarpium citri reticulatae viride, 7.2-8.8% of lotus petiole, 7.2-8.8% of verbena officinalis, 5.4-6.6% of rhizoma curcumae longae, 5.4-6.6% of rhizoma curcumae and 5.4-6.6% of semen lablab album. The Chinese herbal granule has the effects of discharging liver and regulating qi, promoting circulation and removing stasis, clearing heat and promoting fluid, promoting digestion and tonifying spleen, reducing blood sugar and quenching thirsty, strengthening gastric motility and promoting gastrointestinal motility and is convenient to take, good in symptomatic property, rapid to display effects and good in treatment effect, and the cure rate is 90.32 percent.

The present invention provides an extract of betel nut for improving gastric motility and its preparation process and application. The preparation process includes the following steps: take fried betel nut Chinese medicinal material and crush it, and use ether, ethanol, and chloroform in a volume ratio of 1:0.2-0.3:0.03- 0.05 as the extraction solvent, then add carbonate buffer, shake for 20-40 minutes, heat and reflux for 20-40 minutes, collect the extract, repeat the reflux extraction for 2-3 times, combine the total extract, add composite adsorption agent, the composite adsorbent is made of chitosan, diatomaceous earth, and activated carbon, and left to stand for 15-20min; filtered, and the filtrate is concentrated under reduced pressure at 60-70°C to form a thick paste, dried, and obtained. The betel nut extract obtained by the present invention not only significantly improves the transfer rate of arecoline, arecoline, and areca nut polyphenols, but also effectively removes heavy metals such as lead, arsenic, and mercury, improves the activity and safety of the areca nut extract, and can significantly reduce phenols in the stomach of mice. Red residual rate, has a good gastric emptying effect, can be better used in the preparation of drugs to improve gastric motility.

Disclosed herein is a method of treatment of gastric motility disorders and of improving gastric motility comprising treatment with the NK-1 receptor antagonist, tradipitant.

The invention provides a microecological preparation for decomposing ochratoxin and a preparation method thereof. The microecological preparation includes Clostridium butyricum, Bacillus natto, Bacillus coagulans, extract of FOMESOFFICINALIS, sodium butyrate, liquid culture medium and the like. The micro-ecological preparation that can decompose ochratoxin provided by the invention has stable properties, can decompose the pollution caused by ochratoxin in feed, has strong anti-pollution ability, can significantly increase gastrointestinal motility, enhance gastric motility, and relieve gastrointestinal discomfort or bloating, to regulate flatulence.

The invention relates to a stomach power medicine for curing function failure of stomach intestine and its preparing method, prepared of the following raw materials in weight proportion: fried radix bupleuri 5-20, radix paeoniae alba 5-20, Asarum sieboldii 3-8, fuling 10-25, fried Radix scutellariae 10-25, Rhizoma Pinellinae Praeparata 5-20, areca-nut 10-20, raw rheum officinale 5-15, the membrane of a chicken's gizzard 5-20 and fruit of citron or trifoliate orange 5-20. It is used mainly to cure abdominal distension, bellyache, constipation, etc, and achieves better clinic effect in wide application to internal medicine, surgical department and department of orthopedics. It gives full play to the curative advantages of multiple uses and multiple target points of compound traditional Chinese medicine, convenient to take, low-price, having no obvious toxicity and side effect, and it is a pure Chinese medicinal preparation with a good prospect in applying and developing.

The invention discloses a preparation method of traditional Chinese medicine gastric motility medicine, which comprises the following steps: (a) extracting the effective part Muxiang Weitai from Muxiang; The total lactone content of Muxiangweitai raw material is determined by using hydrogen corylidene as a reference substance, and the standard Muxiangweitai raw material is obtained; (c) the Muxiangweitai raw material is prepared into a traditional Chinese medicine Weikine pharmaceutical preparation. Animal experiments show that the traditional Chinese medicine gastric motility drug obtained by the preparation method of the present invention is equivalent to morphine in promoting gastric motility and alleviating gastric motility disorders, and the analgesic effect is better than morphine, but there is no effect of morphine. side effect. The dosage is small and the price is very low.

The invention provides a dropping pill whose active ingredient contains ginkgolide, and the dropping pill also includes polyethylene glycol and sucrose ester. The active ingredients of the dropping pills provided by the invention can be rapidly dissolved and enter the blood, and are expected to improve the bioavailability of people with insufficient gastric motility after taking the ginkgolide lactone dropping pills. Moreover, the dropping pills provided by the present invention containing ginkgolide lactone as an active ingredient have a hardness of 20-25KN, a roundness of 4-5 points, a tailing of 7-9 points, and excellent appearance quality.